APEX PHARMA ApS
CVR 45690776 · Private limited company (ApS) · Active · Low risk
APEX PHARMA ApS is a Private limited company (ApS), founded on , based in Søborg. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 2.0m and a net result of DKK -239k.
Bankruptcy risk for APEX PHARMA ApS
0.4 × the average (1.41%) · higher risk than 66% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45690776
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Transformervej 14
2860 Søborg - Municipality
- Gladsaxe
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 357k
- Auditor
- Baker Tilly Denmark
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 98.3% |
| Current ratio | 5,804% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 37 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK -215k |
| Net profit | DKK -239k |
| Equity | DKK 2.0m |
| Total assets | DKK 2.0m |
| Cash | DKK 2.0m |
| Short-term debt | DKK 35k |
| Avg. employees | 1 |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Baker Tilly Denmark.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 17 Jun 2025 – 31 Dec 2025 | 181 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Peder Brandhof | Current | |
| Board | Lars Patrik Mikael Forsell | Current | |
| Board | Taner Güler | Current | |
| Owner (67%) | KESITA HOLDING ApS | Current | |
| Owner (15%) | KAYA INVEST ApS | Current | |
| Owner (15%) | ELR HOLDING ApS | Current | |
| Owner (100%) | KESITA HOLDING ApS | ||
| Founder | KESITA HOLDING ApS | Current |
Address history (0 moves)
| Transformervej 14, 2860 Søborg |
Other companies at the same address
- A-N Drift ApS Active
- A-N Holding ApS Active
- AZ COUNTING ApS Active
- Aerotak ApS Active
- BK Ejendom Brande ApS Active
- BK Ejendom Greve ApS Active
- BioCulture Nordic ApS Active
- CONVATEC DENMARK A/S Active
- CSI Leasing Denmark A/S Active
- CY Consult ApS Active
- Cheikh-Youssef ApS Active
- Com-ply ApS Active
- Coma System ApS Active
- Design&Relation ApS Active
- ER DENMARK A/S Active
- Harder Copenhagen ApS Active
- Harder Copenhagen Holding ApS Active
- Jysk Muld ApS Active
- Kara Statsautoriseret Revisionsanpartsselskab Active
- Karasan Group ApS Active
- Kongevejen ApS Active
- LuxLimo ApS Active
- MCNEIL DENMARK ApS Active
- MONTANA BYG ApS Active
- PARTNEREN A/S Active
Similar companies in Gladsaxe
- Pierre Fabre Dermo-Cosmétique Nordic A/S Søborg
- MERCK A/S Søborg
- ALMIRALL ApS Søborg
- CONVATEC DENMARK A/S Søborg
- SPECIALBANDAGER.DK A/S Bagsværd
- MCNEIL DENMARK ApS Søborg
- TEVA DENMARK A/S Søborg
- CONTURA A/S Søborg
- MERCK LIFE SCIENCE A/S Søborg
- Hjerte112 A/S Søborg
- Novozymes Biopharma DK A/S Bagsværd
- MEDIVIT ApS Søborg
Questions and answers about APEX PHARMA ApS
Has APEX PHARMA ApS gone bankrupt?
No, APEX PHARMA ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of APEX PHARMA ApS?
Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the auditor of APEX PHARMA ApS?
APEX PHARMA ApS most recently used Baker Tilly Denmark.
When was APEX PHARMA ApS founded?
APEX PHARMA ApS was founded on 17 June 2025.
What is the equity of APEX PHARMA ApS?
Equity was DKK 2.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.